Patent intelligence · EP
EP 2875810
Pharmakologische Behandlung von Zwangsstörungen unter Verwendung von Stiripentol oder einer ähnlichen Verbindung
Pharmakologische Behandlung von Zwangsstörungen unter Verwendung von Stiripentol oder einer ähnlichen Verbindung
Patent details — EP 2875810
- Jurisdiction
- EP
- Status
- granted
- Grant date
- May 27, 2015
- Expiration
- May 22, 2035
- Applicant
- BIOCODEX [FR]
- CPC classes
- A61K 31/ 15 A I, A61K 31/ 36 A I, A61K 31/ 55 A I, A61K 31/ 135 A I
Quick answer
EP 2875810 (Pharmakologische Behandlung von Zwangsstörungen unter Verwendung von Stiripentol oder einer ähnlichen Verbindung) is held by BIOCODEX [FR]. Status: granted. Granted May 27, 2015. Expires May 22, 2035 (9 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- BIOCODEX [FR]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 31/ 15 A I, A61K 31/ 36 A I, A61K 31/ 55 A I, A61K 31/ 135 A I, A61K 31/ 138 A I, A61K 31/ 343 A I
More from BIOCODEX [FR]
Related pharmaceutical patents in our USPTO index.
Frequently asked questions
What is US patent 2875810?
EP 2875810 (Pharmakologische Behandlung von Zwangsstörungen unter Verwendung von Stiripentol oder einer ähnlichen Verbindung) is held by BIOCODEX [FR]. Status: granted. Granted May 27, 2015. Expires May 22, 2035 (9 years remaining) — relevant for patent-cliff and LOE planning.
Who owns EP 2875810?
BIOCODEX [FR] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 2 pharmaceutical patents for this assignee.
When does EP 2875810 expire?
Our index shows an expiration date of May 22, 2035 (9 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.